Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin in cancer
Ritwika Mallik, Tahseen A Chowdhury
Diabetes Research and Clinical Practice (2018) Vol. 143, pp. 409-419
Closed Access | Times Cited: 239

Showing 26-50 of 239 citing articles:

Molecular mechanisms of exercise contributing to tissue regeneration
Jibao Chen, Ren Zhou, Feng Ye, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 68
The Role of Catechins in Regulating Diabetes: An Update Review
Lianghua Wen, Dan Wu, Xindong Tan, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4681-4681
Open Access | Times Cited: 62
Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview
Giuseppe Gullo, Andrea Etrusco, Gaspare Cucinella, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11825-11825
Open Access | Times Cited: 58
Disrupting Circadian Rhythm via the PER1–HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer
Jiao Wang, Qiong Huang, Xingbin Hu, et al.
Cancer Research (2022) Vol. 82, Iss. 8, pp. 1503-1517
Open Access | Times Cited: 57
Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK‐dependent mechanisms
Yizhi Bu, Mei Peng, Xinyi Tang, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 19, pp. 4886-4903
Open Access | Times Cited: 53
Targeting the Metabolic Paradigms in Cancer and Diabetes
Mira Bosso, Dania Haddad, Ashraf Al Madhoun, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 211-211
Open Access | Times Cited: 13
Advances in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic Supplemental Treatment for Glioblastoma
Siddharth Shah, Hadeel M. Mansour, Tania M. Aguilar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5694-5694
Open Access | Times Cited: 11
Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies
Nikolaos Spyrou, Konstantinos Avgerinos, Christos S. Mantzoros, et al.
Current Obesity Reports (2018) Vol. 7, Iss. 4, pp. 260-275
Closed Access | Times Cited: 68
Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
Dan Jin, Jiwei Guo, Yan Wu, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 54
The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Yongchao Zhang, Hualei Chen, Shanshan Chen, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 53
Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
Luiz Paulo Chaves, Camila Morais Melo, Fabiano Pinto Saggioro, et al.
Genes (2021) Vol. 12, Iss. 12, pp. 1900-1900
Open Access | Times Cited: 49
Discovery and development of tumor glycolysis rate-limiting enzyme inhibitors
Xueyan Sun, Yijiao Peng, Jingduo Zhao, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104891-104891
Closed Access | Times Cited: 48
Fertility-sparing management for endometrial cancer: review of the literature
Simone Garzon, Stefano Uccella, Pier Carlo Zorzato, et al.
Minerva Medica (2021) Vol. 112, Iss. 1
Closed Access | Times Cited: 44
NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future
Sandra Ramos-Inza, Ana Carolina Ruberte, Carmen Sanmartín, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16380-16421
Closed Access | Times Cited: 42
Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks
Vincenzo Sorrenti, Francesca Benedetti, Alessandro Buriani, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 912-912
Open Access | Times Cited: 36
TME-triggered MnSiO3@Met@GOx nanosystem for ATP dual-inhibited starvation/chemodynamic synergistic therapy
Jiayao Zhang, Liang Chen, Ziye Wei, et al.
Biomaterials (2022) Vol. 287, pp. 121682-121682
Closed Access | Times Cited: 33
Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4
Cong-Jie Chen, Jieyun Huang, Jianqing Huang, et al.
Cell Cycle (2023) Vol. 22, Iss. 8, pp. 986-1004
Open Access | Times Cited: 22
Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer
Bo Peng, Siyuan Zhang, Ka Iong Chan, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 740-740
Open Access | Times Cited: 20
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Yi Zhang, Fang Zhou, Jiaheng Guan, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 250-250
Open Access | Times Cited: 19
The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3161-3161
Open Access | Times Cited: 19
Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3
Zongqiang Hu, Yingpeng Zhao, Laibang Li, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 8, pp. 6399-6413
Open Access | Times Cited: 19
Wastewater analysis reveals spatial pattern in consumption of anti-diabetes drug metformin in China
Ji-Hao Yan, Xiao Yang, Dongqin Tan, et al.
Chemosphere (2019) Vol. 222, pp. 688-695
Closed Access | Times Cited: 54
High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
Sharon Varghese, Samson Mathews Samuel, Elizabeth Varghese, et al.
Biomolecules (2019) Vol. 9, Iss. 1, pp. 16-16
Open Access | Times Cited: 53
Therapy of Type 2 Diabetes
Rüdiger Landgraf, Jens Aberle, Andreas L. Birkenfeld, et al.
Experimental and Clinical Endocrinology & Diabetes (2019) Vol. 127, Iss. S 01, pp. S73-S92
Open Access | Times Cited: 50
NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyond
Daria Capece, Daniela Verzella, Barbara Di Francesco, et al.
Seminars in Cell and Developmental Biology (2019) Vol. 98, pp. 118-128
Closed Access | Times Cited: 48

Scroll to top